TD Cowen Maintains Hold on Legend Biotech, Lowers Price Target to $24

Legend Biotech

Legend Biotech

LEGN

0.00

TD Cowen analyst Yaron Werber maintains Legend Biotech (NASDAQ: LEGN) with a Hold and lowers the price target from $29 to $24.